Patient Pathfinder: Clinical Trials
Clinical Trials for Melanoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 451 active Melanoma trials
UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma
Study Type: Interventional Phase 1
Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
Study Type: Interventional Phase 2
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Study Type: Interventional Phase 2
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Study Type: Interventional Phase 1
Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry
Study Type: Interventional
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Study Type: Observational
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma
Study Type: Observational
Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
Study Type: Interventional Phase 2
There are 451 active Melanoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now